Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes (BEACON)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01351675 |
Recruitment Status :
Terminated
(IDMC recommendation for safety concerns)
First Posted : May 11, 2011
Last Update Posted : May 14, 2014
|
Sponsor:
Reata Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | October 2012 |
Actual Study Completion Date : | December 2012 |
Certification/Extension First Submitted : | April 28, 2014 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):